Transcription of SMAD7 and S1PR1 is decreased in the peripheral blood CD4+ T lymphocytes of RRMS patients during acute relapses and in remitting phases, and in CD patients compared with healthy donors. The gene discussed is S1PR1; the disease is relapsing-remitting multiple sclerosis.